The store will not work correctly when cookies are disabled.
(3,9-Diazaspiro[5.5]undecan-3-yl)(m-tolyl)methanone
ID: ALA5187612
PubChem CID: 120489128
Max Phase: Preclinical
Molecular Formula: C17H24N2O
Molecular Weight: 272.39
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(C(=O)N2CCC3(CCNCC3)CC2)c1
Standard InChI: InChI=1S/C17H24N2O/c1-14-3-2-4-15(13-14)16(20)19-11-7-17(8-12-19)5-9-18-10-6-17/h2-4,13,18H,5-12H2,1H3
Standard InChI Key: FRKWUXZCSLOPIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
34.9861 -2.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7011 -3.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4131 -2.7391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4164 -1.9141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7014 -1.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9832 -1.9118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5603 -2.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5603 -3.5623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2748 -3.9698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9893 -3.5623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2748 -2.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1303 -1.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1324 -0.6730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8405 -1.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8388 -2.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5507 -3.1480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2646 -2.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2623 -1.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5499 -1.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9738 -1.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
18 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.39 | Molecular Weight (Monoisotopic): 272.1889 | AlogP: 2.60 | #Rotatable Bonds: 1 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 2.08 | CX LogD: -0.68 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -1.05 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |